GABA(B) Receptor Modulation Of Gastrointestinal Function In Health And Disease By Alpha-Conotoxins
Funder
National Health and Medical Research Council
Funding Amount
$689,050.00
Summary
Chronic visceral pain is a common and debilitating condition arising from numerous diseases that affect our internal organs. There is a desperate need for more information about the mechanisms responsible for signalling chronic visceral pain to provide therapies and potentially find a cure for it. Our research focuses on ?-conotoxins (small peptides from marine cone snail venom) as novel potential therapeutic agents for the treatment of chronic visceral pain.
Industrial Transformation Research Hubs - Grant ID: IH200100023
Funder
Australian Research Council
Funding Amount
$4,950,000.00
Summary
ARC Research Hub for Innovative Nitrogen Fertilisers and Inhibitors. This Hub aims to transform agriculture by delivering a new class of nitrogen (N) fertilisers and inhibitors designed to stem the 50-80% losses to the environment in current products. It is intended to generate new knowledge and valuable intellectual property in controlled released and coated N fertiliser products using a novel co-design process involving representatives of the whole value chain from product design through to va ....ARC Research Hub for Innovative Nitrogen Fertilisers and Inhibitors. This Hub aims to transform agriculture by delivering a new class of nitrogen (N) fertilisers and inhibitors designed to stem the 50-80% losses to the environment in current products. It is intended to generate new knowledge and valuable intellectual property in controlled released and coated N fertiliser products using a novel co-design process involving representatives of the whole value chain from product design through to validation and adoption. The project estimates possible 20% gains in efficiency of N use, delivering large costs savings, improved productivity, increased profitability and decreased environmental impacts, helping the Australian food and agribusiness sector to reach its 2030 target of $100B value added.Read moreRead less